Respiratory/Pulmonary Market Research Reports & Industry Analysis
Respiratory/Pulmonary Industry Research & Market Reports
-
Europe Carbapenem-Based Antibiotics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Meropenem, Doripenem, Imipenem, Tebipenem, and Others), Indication (Bacterial Meningitis, Acute Pelvic Infections, Respiratory Tract Infections, Intra-Abdominal Infections, Urinary Tract Infections, and Others), and Distribution Channel (Retail Pharmacies, Online Pharmacies, and Hospital Pharmacies)
... and Others), and Distribution Channel (Retail Pharmacies, Online Pharmacies, and Hospital Pharmacies) The Europe carbapenem-based antibiotics market is expected to reach US$ 1,469.86 million by 2028 from US$ 1,128.37 million in 2021; it is estimated ... Read More
-
Asia Pacific Carbapenem-Based Antibiotics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Meropenem, Doripenem, Imipenem, Tebipenem, and Others), Indication (Bacterial Meningitis, Acute Pelvic Infections, Respiratory Tract Infections, Intra-Abdominal Infections, Urinary Tract Infections, and Others), and Distribution Channel (Retail Pharmacies, Online Pharmacies, and Hospital Pharmacies)
... Infections, and Others), and Distribution Channel (Retail Pharmacies, Online Pharmacies, and Hospital Pharmacies) The Asia Pacific carbapenem-based antibiotics market is expected to reach US$ 1,506.07 million by 2028 from US$ 1,072.76 million in 2021; it ... Read More
-
Small Cell Lung Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update
... Lung Cancer therapeutics. Synopsis In 2022, there will be more than 210,000 diagnosed prevalent cases of SCLC across 16 pharmaceutical markets. There are three leading marketed drugs for the treatment of SCLC, AstraZeneca is a ... Read More
-
Asia Pacific Non-Invasive Ventilation Masks Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Non-Invasive Ventilation Reusable Masks and Non-Invasive Ventilation Disposable Masks), Application (Respiratory Dysfunction, Chronic Obstructive Pulmonary Diseases, Pneumonia, and Others), and End User (Pediatric, ICU, Home Care, and Others)
... Others), and End User (Pediatric, ICU, Home Care, and Others) The Asia Pacific non-invasive ventilation masks market is expected to reach US$ 581.8 million by 2028 from US$ 384.8 million in 2021. The market is ... Read More
-
Europe Non-Invasive Ventilation Masks Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Non-Invasive Ventilation Reusable Masks and Non-Invasive Ventilation Disposable Masks), Application (Respiratory Dysfunction, Chronic Obstructive Pulmonary Diseases, Pneumonia, and Others), and End User (Pediatric, ICU, Home Care, and Others)
... and End User (Pediatric, ICU, Home Care, and Others) The Europe non-invasive ventilation masks market is expected to reach US$ 735.24 million by 2028 from US$ 515.45 million in 2021. The market is estimated to ... Read More
-
North America Non-Invasive Ventilation Masks Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Non-Invasive Ventilation Reusable Masks and Non-Invasive Ventilation Disposable Masks), Application (Respiratory Dysfunction, Chronic Obstructive Pulmonary Diseases, Pneumonia, and Others), and End User (Pediatric, ICU, Home Care, and Others)
... Others), and End User (Pediatric, ICU, Home Care, and Others) The North America non-invasive ventilation masks market is expected to reach US$ 985.8 million by 2028 from US$ 671.1 million in 2021. The market is ... Read More
-
South and Central America Non-Invasive Ventilation Masks Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Non-Invasive Ventilation Reusable Masks and Non-Invasive Ventilation Disposable Masks), Application (Respiratory Dysfunction, Chronic Obstructive Pulmonary Diseases, Pneumonia, and Others), and End User (Pediatric, ICU, Home Care, and Others)
... Pneumonia, and Others), and End User (Pediatric, ICU, Home Care, and Others) The South & Central America non-invasive ventilation masks market is expected to reach US$ 166.2 million by 2028 from US$ 119.8 million in ... Read More
-
Middle East and Africa Non-Invasive Ventilation Masks Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Non-Invasive Ventilation Reusable Masks and Non-Invasive Ventilation Disposable Masks), Application (Respiratory Dysfunction, Chronic Obstructive Pulmonary Diseases, Pneumonia, and Others), and End User (Pediatric, ICU, Home Care, and Others)
... Pneumonia, and Others), and End User (Pediatric, ICU, Home Care, and Others) The Middle East & Africa non-invasive ventilation masks market is expected to reach US$ 114.0 million by 2028 from US$ 84.2 million in ... Read More
-
North America Carbapenem-Based Antibiotics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Meropenem, Doripenem, Imipenem, Tebipenem, and Others), Indication (Bacterial Meningitis, Acute Pelvic Infections, Respiratory Tract Infections, Intra-Abdominal Infections, Urinary Tract Infections, and Others), and Distribution Channel (Retail Pharmacies, Online Pharmacies, and Hospital Pharmacies)
... Infections, and Others), and Distribution Channel (Retail Pharmacies, Online Pharmacies, and Hospital Pharmacies) The North America carbapenem-based antibiotics market is expected to reach US$ 1,713.21 million by 2028 from US$ 1,244.59 million in 2021; it ... Read More
-
Bacteriophage Market
... assessment of the most important market dynamics. On conducting thorough research on the historical as well as current growth parameters of the bacteriophage market, growth prospects of the market are obtained with maximum precision. The ... Read More
-
2022-2026 Global Respiratory Syncytial Virus (RSV) Diagnostic Testing Market: US, Europe, Japan-Supplier Shares, Volume and Sales Segment Forecasts, Competitive Analysis, Emerging Technologies, Instrumentation Review, Opportunities for Suppliers
... Respiratory Syncytial Virus diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Respiratory Syncytial Virus definition, epidemiology and etiology are reviewed. The report provides the 5-year ... Read More
-
Leading Cystic Fibrosis Therapeutics Distribution Channel Markets Databank
... from 2021 to 2029. Hospital segment is expected to be the highest contributor to this market, with $3,622.8 Million in 2020, and is anticipated to reach $4,436.7 Million by 2029, registering a CAGR of 2.32%. ... Read More
-
North America Respiratory Protective Equipment Market Databank
... 2021 to 2029. Air-Purifying Respirators (APR) segment is expected to be the highest contributor to this market, with $9,163.2 Million in 2020, and is anticipated to reach $12,592.6 Million by 2029, registering a CAGR of ... Read More
-
Asia-Pacific Respiratory Protective Equipment Market Databank
... to 2029. Air-Purifying Respirators (APR) segment is expected to be the highest contributor to this market, with $9,163.2 Million in 2020, and is anticipated to reach $12,592.6 Million by 2029, registering a CAGR of 3.64%. ... Read More
-
Leading Respiratory Protective Equipment Product Markets Databank
... 2021 to 2029. Air-Purifying Respirators (APR) segment is expected to be the highest contributor to this market, with $9,163.2 Million in 2020, and is anticipated to reach $12,592.6 Million by 2029, registering a CAGR of ... Read More
-
2022 Global In Vitro Lung Model Industry (2028 Outlook)
... Global Advanced Market Outlook reports provide market size data for a three-year historical trend (2016-2019), a three-year forecast estimate trends (2020-2023), and a five-year outlook projection (2023-2028) for 46 countries. Market and product shipments include ... Read More
-
Global Cystic Fibrosis Therapeutics Market Databank
... to 2029. Hospital segment is expected to be the highest contributor to this market, with $3,622.8 Million in 2020, and is anticipated to reach $4,436.7 Million by 2029, registering a CAGR of 2.32%. Retail pharmacies ... Read More
-
Latin America, Middle East & Africa Respiratory Protective Equipment Market Databank
... CAGR of 3.69% from 2021 to 2029. Air-Purifying Respirators (APR) segment is expected to be the highest contributor to this market, with $9,163.2 Million in 2020, and is anticipated to reach $12,592.6 Million by 2029, ... Read More
-
Europe Respiratory Protective Equipment Market Databank
... to 2029. Air-Purifying Respirators (APR) segment is expected to be the highest contributor to this market, with $9,163.2 Million in 2020, and is anticipated to reach $12,592.6 Million by 2029, registering a CAGR of 3.64%. ... Read More
-
Leading Respiratory Protective Equipment End User Markets Databank
... from 2021 to 2029. Healthcare segment is expected to be the highest contributor to this market, with $8,070.9 Million in 2020, and is anticipated to reach $11,029.1 Million by 2029, registering a CAGR of 3.57%. ... Read More
-
Global Respiratory Protective Equipment Market Databank
... to 2029. Air-Purifying Respirators (APR) segment is expected to be the highest contributor to this market, with $9,163.2 Million in 2020, and is anticipated to reach $12,592.6 Million by 2029, registering a CAGR of 3.64%. ... Read More
-
Leading Respiratory Protective Equipment Country Markets Databank
... 2021 to 2029. North America is expected to be the highest contributor to this market, with $5,372.6 Million in 2020, and is anticipated to reach $7,088.5 Million by 2029, registering a CAGR of 3.16%. Asia-Pacific ... Read More
-
Europe Cystic Fibrosis Therapeutics Market Databank
... to 2029. Hospital segment is expected to be the highest contributor to this market, with $3,622.8 Million in 2020, and is anticipated to reach $4,436.7 Million by 2029, registering a CAGR of 2.32%. Retail pharmacies ... Read More
-
Leading Cystic Fibrosis Therapeutics Country Markets Databank
... 2021 to 2029. Asia-Pacific is expected to be the highest contributor to this market, with $3,196.0 Million in 2020, and is anticipated to reach $4,216.6 Million by 2029, registering a CAGR of 3.16%. Asia-Pacific and ... Read More
-
Asia-Pacific Cystic Fibrosis Therapeutics Market Databank
... to 2029. Hospital segment is expected to be the highest contributor to this market, with $3,622.8 Million in 2020, and is anticipated to reach $4,436.7 Million by 2029, registering a CAGR of 2.32%. Retail pharmacies ... Read More
Research Assistance
